Acorda Therapeutics Contracts & Agreements
185 Contracts & Agreements
- Business Finance (45 contracts)
- Business Operations (25)
- Human Resources (27)
- Intellectual Property (25)
- Mergers & Acquisitions (3)
- Real Estate (4)
- Uncategorized (56)
- Amended and restated employment letter agreement, dated June 2, 2022, by and between the Registrant and Lauren Sabella (Filed With SEC on August 9, 2022)
- Amended and restated employment letter agreement, dated June 2, 2022, by and between the Registrant and Kerry Clem (Filed With SEC on August 9, 2022)
- Employment letter agreement, dated June 2, 2022, by and between the Registrant and Michael Gesser (Filed With SEC on August 9, 2022)
- Employment letter agreement, dated June 2, 2022, by and between the Registrant and Neil S. Belloff (Filed With SEC on August 9, 2022)
- Acorda Therapeutics 2016 Inducement Plan (Filed With SEC on March 18, 2022)
- Form of stock option certificate under the Acorda Therapeutics 2016 Inducement Plan (Filed With SEC on March 18, 2022)
- Amendment dated January 6, 2022, to June 8, 2015 Employment Agreement by and between the Registrant and Lauren Sabella (Filed With SEC on March 18, 2022)
- Separation Agreement and General Release dated December 31, 2021, by and between the Registrant and Burkhard Blank, M.D (Filed With SEC on March 18, 2022)
- Master Consulting Agreement, dated as of January 1, 2022, and Schedule #1 under the Master Consulting Agreement, by and between the Registrant and Burkhard Blank, M.D (Filed With SEC on March 18, 2022)
- Employment offer letter, dated November 4, 2021, by and between the Registrant and Michael Gesser (Filed With SEC on March 18, 2022)
- Employment offer letter, dated November 4, 2021, by and between the Registrant and Neil Belloff (Filed With SEC on March 18, 2022)
- First Amendment to Manufacturing Services Agreement dated as of October 28, 2021, by and between the Registrant and Catalent Massachusetts, LLC (Filed With SEC on March 18, 2022)
- Second Amendment to Manufacturing Services Agreement dated as of December 31, 2021, by and between the Registrant and Catalent Massachusetts, LLC (Filed With SEC on March 18, 2022)
- Employment Agreement dated September 1, 2020, by and between the Company and Kerry Clem (Filed With SEC on September 9, 2021)
- Form of time-based vesting Restricted Stock Unit Agreement for awards under the Acorda Therapeutics, Inc. 2015 Omnibus Incentive Compensation Plan (Filed With SEC on May 12, 2021)
- Severance policies applicable to Robert Morales, Vice President, Finance and Controller, and interim principal financial and accounting officer (Filed With SEC on May 12, 2021)
- Acorda Therapeutics, Inc. Directors Compensation Policy, as amended April 15, 2021 (Filed With SEC on May 12, 2021)
- Specimen stock certificate evidencing shares of common stock (Filed With SEC on March 16, 2021)
- Description of Common Stock (Filed With SEC on March 16, 2021)
- Asset Purchase Agreement, dated as of January 12, 2021, between the Registrant and Catalent Pharma Solutions, Inc (Filed With SEC on March 16, 2021)
- Manufacturing Services Agreement, dated February 10, 2021, between the Registrant and Catalent Massachusetts LLC (Filed With SEC on March 16, 2021)
- At The Market Offering Agreement, dated January 13, 2021, between Acorda Therapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on January 13, 2021)
- Description of Common Stock (Filed With SEC on February 28, 2020)
- Consulting Agreement, dated November 11, 2019, by and between the Registrant and Jane Wasman (Filed With SEC on February 28, 2020)
- Form of Exchange Agent Agreement, dated as of December 20, 2019, among the Company, the guarantors party thereto, and the holder named therein (Filed With SEC on December 26, 2019)
- Security Agreement, dated as of December 23, 2019, from the grantors named therein to Wilmington Trust, National Association, as collateral agent (Filed With SEC on December 26, 2019)
- Registration Rights Agreement, dated as of December 20, 2019, among the Company and the investors party thereto (Filed With SEC on December 26, 2019)
- Indenture, dated as of December 23, 2019, among the Company, the guarantors party thereto, and Wilmington Trust, National Association, as trustee and collateral agent (Filed With SEC on December 26, 2019)
- Amendment to December 19, 2005 Employment Agreement, dated August 13, 2019, by and between the Registrant and David Lawrence (Filed With SEC on November 7, 2019)
- Amendment to December 19, 2005 Employment Agreement, dated August 13, 2019, by and between the Registrant and Jane Wasman (Filed With SEC on November 7, 2019)
- Amendment D, dated March 29, 2018, by and between North River Everett Ave, LLC and Civitas Therapeutics, Inc (Filed With SEC on May 9, 2018)
- Cooperation Agreement, dated as of February 27, 2018, between the Company and Scopia (Filed With SEC on February 28, 2018)
- Amendment C, dated October 11, 2017, by and between North River Everett Ave, LLC and Civitas Therapeutics, Inc (Filed With SEC on November 7, 2017)
- Rights Agreement, dated as of August 31, 2017, between Acorda Therapeutics, Inc. and Computershare Trust Company, N.A, as Rights Agent, which includes the Form of Certificate of... (Filed With SEC on September 1, 2017)
- Revised forms of equity award documents for certain awards under the Acorda Therapeutics, Inc. 2015 Omnibus Incentive Compensation Plan (Filed With SEC on August 8, 2017)
- PERFORMANCE UNIT AGREEMENT (Filed With SEC on November 7, 2016)
- Acorda Announces Patent Trials and Appeal Board (PTAB) Institutes IPRs of AMPYRA Patents (Filed With SEC on March 11, 2016)
- ASSIGNMENT AND AMENDMENT OF LEASE (Filed With SEC on February 29, 2016)
- Combination Agreement between Acorda Therapeutics, Inc. and Biotie Therapies Corp. 19 January 2016 (Filed With SEC on January 19, 2016)
- AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER (Filed With SEC on August 7, 2015)
- FIRST AMENDMENT TO LEASE (Filed With SEC on August 7, 2015)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 7, 2015)
- FIRST AMENDMENT TO EXECUTIVE EMPOYMENT AGREEMENT (Filed With SEC on August 7, 2015)
- SECOND AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 7, 2015)
- FORMS OF EQUITY AWARD DOCUMENTSFOR AWARDS UNDER THE ACORDA THERAPEUTICS, INC. 2015 OMNIBUS INCENTIVE COMPENSATION PLAN (Filed With SEC on August 7, 2015)
- CIVITAS THERAPEUTICS, INC. c/o ACORDA THERAPEUTICS, INC. 420 SAW MILL RIVER ROAD ARDSLEY, NY10502 (Filed With SEC on May 8, 2015)
- ACORDA THERAPEUTICS, INC. 2006 Employee Stock Option Plan Non-Statutory Stock Option Certificate (Filed With SEC on February 27, 2015)
- RESTRICTED STOCK AGREEMENT (Filed With SEC on February 27, 2015)
- LEASE (Filed With SEC on February 27, 2015)
- AMENDMENT A (Filed With SEC on February 27, 2015)
- AMENDMENT B (Filed With SEC on February 27, 2015)
- SUBLEASE (Filed With SEC on February 27, 2015)
- ASSET PURCHASE AND LICENSE AGREEMENT BY AND BETWEEN ALKERMES, INC. AND CORREGIDOR THERAPEUTICS, INC. DECEMBER 27, 2010 (Filed With SEC on February 27, 2015)
- AMENDMENT TO ASSET PURCHASE AND LICENSE AGREEMENT (Filed With SEC on February 27, 2015)
- SECOND AMENDMENT TO ASSET PURCHASE AND LICENSE AGREEMENT (Filed With SEC on February 27, 2015)
- BMRArdsley Park LLC 17190 Bernardo Center Drive"San Diego, California92128 Phone: (858) 485-9840"Facsimile: (858) 485-9843 (Filed With SEC on November 7, 2014)
- ________________________________________ AGREEMENT AND PLAN OF MERGER BY AND AMONG ACORDA THERAPEUTICS, INC. FIVE A ACQUISITION CORPORATION, CIVITAS THERAPEUTICS, INC. AND... (Filed With SEC on September 26, 2014)
- SUPPLY AGREEMENT BETWEEN ACORDA THERAPEUTICS, INC. AND BIOGEN IDEC INTERNATIONAL GMBH (Filed With SEC on August 7, 2014)
- ACORDATHERAPEUTICS, INC. 1.75% Convertible Notes due June 15, 2021 Underwriting Agreement June 17, 2014 (Filed With SEC on June 23, 2014)
- ACORDA THERAPEUTICS, INC., Company AND WILMINGTON TRUST, NATIONAL ASSOCIATION, Trustee INDENTURE Dated as of June 23, 2014 Senior Debt Securities CROSS-REFERENCE TABLE* (Filed With SEC on June 23, 2014)
- ACORDA THERAPEUTICS, INC. AND WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee FIRST SUPPLEMENTALINDENTURE Dated as of June 23, 2014 to Indenture Dated as ofJune 23, 2014 1.75%... (Filed With SEC on June 23, 2014)
- LICENSE AGREEMENT (Filed With SEC on May 9, 2014)
- ASSET PURCHASE AGREEMENT by and between ELAN PHARMACEUTICALS, INC. and ACORDA THERAPEUTICS, INC. dated as of July21, 2004 (Filed With SEC on May 9, 2014)
- RESTRICTED STOCK AGREEMENT (Filed With SEC on March 3, 2014)
- Revised (Filed With SEC on November 7, 2013)
- CONFIDENTIAL February 14, 2013 (Filed With SEC on May 10, 2013)
- CONFIDENTIAL (Filed With SEC on May 10, 2013)
- CONFIDENTIAL March 29, 2012 (Filed With SEC on February 28, 2013)
- LICENSE AGREEMENT (Filed With SEC on February 28, 2013)
- AGREEMENT AND PLAN OF MERGER among: Acorda Therapeutics, Inc., a Delaware corporation; ATI Development Corp., a Delaware corporation; Neuronex, Inc., a Delaware corporation; and... (Filed With SEC on May 9, 2012)
- AMENDMENT #1 TO THE LICENSE AGREEMENT (Filed With SEC on May 9, 2012)
- CONSULTING AGREEMENT (Filed With SEC on February 28, 2012)
- - 2 - (Filed With SEC on February 28, 2012)
- - 2 - (Filed With SEC on February 28, 2012)
- - 2 - (Filed With SEC on February 28, 2012)
- - 2 - (Filed With SEC on February 28, 2012)
- - 2 - (Filed With SEC on February 28, 2012)
- LICENSE AGREEMENT by and between RUSH-PRESBYTERIAN-ST. LUKES MEDICAL CENTER and ACORDA THERAPEUTICS, INC. (Filed With SEC on August 8, 2011)
- LICENSE AGREEMENT (Filed With SEC on August 8, 2011)
- Date:26,September2003 ELAN CORPORATION, PLC. AND ACORDA THERAPEUTICS, INC. AMENDED AND RESTATED LICENSE AGREEMENT INDEX (Filed With SEC on May 9, 2011)
- LICENSE AGREEMENT (Filed With SEC on May 9, 2011)
- ELAN PHARMA INTERNATIONAL LIMITED AND ACORDA THERAPEUTICS, INC. (Filed With SEC on May 9, 2011)
- AMENDMENT #1 TO LICENSE AGREEMENT (Amendment #1) (Filed With SEC on May 9, 2011)
- Forms of Equity Award Documents (Filed With SEC on March 1, 2011)
- Acorda Therapeutics, Inc. 4,000,000 Shares Common Stock UNDERWRITING AGREEMENT dated August 6, 2008 DEUTSCHE BANK SECURITIES INC. (Filed With SEC on August 7, 2008)
- Acorda Therapeutics, Inc. 3,300,000 Shares Common Stock UNDERWRITING AGREEMENT dated February 12,2008 J.P.Morgan Securities Inc. DeutscheBank Securities Inc. (Filed With SEC on February 14, 2008)
- Acorda Therapeutics, Inc. 3,750,000 Shares Common Stock UNDERWRITING AGREEMENT dated June 7, 2007 Banc of America Securities LLC Deutsche Bank Securities Inc. (Filed With SEC on June 8, 2007)
- FIRST AMENDMENT TO REVENUE INTERESTS ASSIGNMENT AGREEMENT AND TO GUARANTY (Filed With SEC on November 29, 2006)
- INTRODUCTION (Filed With SEC on October 6, 2006)
- INTRODUCTION (Filed With SEC on October 5, 2006)
- Acorda Therapeutics, Inc. [] Shares Common Stock UNDERWRITING AGREEMENT dated [], 2006 Banc ofAmerica Securities LLC LazardCapital Markets LLC PiperJaffray & Co. SGCowen & Co., LLC (Filed With SEC on February 3, 2006)
- ACORDATHERAPEUTICS, INC. 2006EMPLOYEE INCENTIVE PLAN As Amendedas of January 13, 2006 (Filed With SEC on January 18, 2006)
- NOTEMODIFICATION AND AMENDMENT (Filed With SEC on January 18, 2006)
- STOCK WARRANTAGREEMENT To Purchase 40,000Shares of the Common Stock of ACORDATHERAPEUTICS, INC. Dated effective asof May 1, 1996 (Filed With SEC on January 5, 2006)
- WARRANT (Filed With SEC on January 5, 2006)
- ACORDA THERAPEUTICS, INC. 2006 EMPLOYEE INCENTIVE PLAN (Filed With SEC on January 5, 2006)
- Employment Agreement (Filed With SEC on January 5, 2006)
- Employment Agreement (Filed With SEC on January 5, 2006)
- EmploymentAgreement (Filed With SEC on January 5, 2006)
- Employment Agreement (Filed With SEC on January 5, 2006)
- NOTEMODIFICATION AND AMENDMENT (Filed With SEC on January 5, 2006)
- REVENUE INTERESTS ASSIGNMENT AGREEMENT Dated as of December 23, 2005 between ACORDA THERAPEUTICS, INC. and KING GEORGE HOLDINGS LUXEMBOURG IIA S. R.L. (Filed With SEC on January 5, 2006)
- WARRANT (Filed With SEC on November 29, 2005)
- Number AT Shares INCORPORATED UNDER THE LAWS CUSIP 00484M 10 6 OF THE STATE OF DELAWARE SEE REVERSE FOR CERTAIN DEFINITIONS (Filed With SEC on October 5, 2005)
- SECOND CLOSING WARRANT To Purchase Shares of the Series B Preferred Stock of ACORDA THERAPEUTICS, INC. (Filed With SEC on October 5, 2005)
- ACORDATHERAPEUTICS, INC. 1999EMPLOYEE STOCK OPTION PLAN (Filed With SEC on October 5, 2005)
- AMENDMENT TO 1999 EMPLOYEE STOCK OPTION PLAN (Filed With SEC on October 5, 2005)
- AMENDMENT NO. 2 TO 1999 EMPLOYEE STOCK OPTION PLAN (Filed With SEC on October 5, 2005)
- SIXTHAMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (Filed With SEC on October 5, 2005)
- ACORDA Therapeutics (Filed With SEC on October 5, 2005)
- ACRDA THERAPEUTICS September 26, 2005 (Filed With SEC on October 5, 2005)
- ACRDA THERAPEUTICS (Filed With SEC on October 5, 2005)
- Date: September 2003 ELAN CORPORATION, PLC. AND ACORDA THERAPEUTICS, INC. AMENDED AND RESTATED LICENSEAGREEMENT (Filed With SEC on October 5, 2005)
- Date: September 2003 ELAN CORPORATION,PLC. AND ACORDA THERAPEUTICS,INC. SUPPLY AGREEMENT (Filed With SEC on October 5, 2005)
- LICENSE AGREEMENT by and between RUSH-PRESBYTERIAN-ST. LUKES MEDICAL CENTER and ACORDA THERAPEUTICS, INC. 1 (Filed With SEC on October 5, 2005)
- SIDE AGREEMENT (Filed With SEC on October 5, 2005)
- RUSH PAYMENTS AGREEMENT (Filed With SEC on October 5, 2005)
- AMENDMENT No. 1 TO RUSH PAYMENTS AGREEMENT (Filed With SEC on October 5, 2005)
- AMENDEDAND RESTATED LICENSE AGREEMENT by and between CANADIANSPINAL RESEARCH ORGANIZATION and ACORDATHERAPEUTICS, INC. (Filed With SEC on October 5, 2005)
- LICENSEAGREEMENT (Filed With SEC on October 5, 2005)
- LICENSE AGREEMENT (Filed With SEC on October 5, 2005)
- LICENSE AGREEMENT (Filed With SEC on October 5, 2005)
- LICENSE AGREEMENT BETWEEN ACORDA THERAPEUTICS, INC. AND THE MAYO FOUNDATION FOR EDUCATION AND RESEARCH Dated:September 8, 2000 (Filed With SEC on October 5, 2005)
- UNIVERSITY OF MINNESOTA SERVICES AGREEMENT (Filed With SEC on October 5, 2005)
- ASSETPURCHASE AGREEMENT byand between ELAN PHARMACEUTICALS, INC. and ACORDATHERAPEUTICS, INC. datedas of July 21, 2004 (Filed With SEC on October 5, 2005)
- ELAN PHARMA INTERNATIONAL LIMITED AND ACORDA THERAPEUTICS, INC, ZANAFLEX SUPPLY AGREEMENT (Filed With SEC on October 5, 2005)
- ASSIGNMENT AND ASSUMPTION AGREEMENT (Filed With SEC on October 5, 2005)
- LICENSE AGREEMENT (Filed With SEC on October 5, 2005)
- PATENT ASSIGNMENTAGREEMENT (Filed With SEC on October 5, 2005)
- TRADEMARK LICENSE AGREEMENT (Filed With SEC on October 5, 2005)
- AGREEMENT RELATING TO ADDITIONAL TRADEMARK (Filed With SEC on October 5, 2005)
- DOMAIN NAME ASSIGNMENT AGREEMENT (Filed With SEC on October 5, 2005)
- BILL OF SALE ANDASSIGNMENT AND ASSUMPTION AGREEMENT (Filed With SEC on October 5, 2005)
- ACORDATHERAPEUTICS, INC. LIMITEDRECOURSE CONVERTIBLE PROMISSORY NOTE (Filed With SEC on October 5, 2005)
- ACORDA THERAPEUTICS, INC. FULL RECOURSE CONVERTIBLE PROMISSORY NOTE (Filed With SEC on October 5, 2005)
- SECURITIES AMENDMENT AGREEMENT AMONG ELAN CORPORATION, PLC, ELAN INTERNATIONAL SERVICES, LTD. AND ACORDATHERAPEUTICS, INC. (Filed With SEC on October 5, 2005)
- FampridineTablets (10mg, 15mg, 20mg, 25mg) Technical Transfer Program Proposal for Commercial Registration For AcordaTherapeutics ProposalNo. ELN-FQ-0001-1002-R4 Dated: February... (Filed With SEC on October 5, 2005)
- SYNDICATED SALES FORCE AGREEMENT (Filed With SEC on October 5, 2005)
- LICENSE AGREEMENT (Filed With SEC on October 5, 2005)
- PROMISSORY NOTE (Filed With SEC on October 5, 2005)
- ACORDA Therapeutics (Filed With SEC on November 28, 2003)
- TERMINATIONAND ASSIGNMENT AGREEMENT ELANCORPORATION, PLC ELANINTERNATIONAL SERVICES, LTD. ACORDA THERAPEUTICS, Inc. MSRESEARCH AND DEVELOPMENT CORPORATION INDEX (Filed With SEC on November 28, 2003)
- Date: September 2003 ELAN CORPORATION, PLC. AND ACORDA THERAPEUTICS, INC. AMENDED AND RESTATED LICENSEAGREEMENT INDEX (Filed With SEC on November 28, 2003)
- Date: September2003 ELAN CORPORATION,PLC. AND ACORDA THERAPEUTICS,INC. SUPPLY AGREEMENT (Filed With SEC on November 28, 2003)
- LICENSE AGREEMENT by and between RUSH-PRESBYTERIAN-ST.LUKES MEDICAL CENTER and ACORDA THERAPEUTICS,INC. 1 (Filed With SEC on November 28, 2003)
- RUSH PAYMENTS AGREEMENT (Filed With SEC on November 28, 2003)
- AMENDEDAND RESTATED LICENSE AGREEMENT by and between CANADIANSPINAL RESEARCH ORGANIZATION and ACORDATHERAPEUTICS, INC. (Filed With SEC on November 28, 2003)
- LICENSEAGREEMENT (Filed With SEC on November 28, 2003)
- RXPEDITE ACORDA MARKETING SERVICES AGREEMENT (Filed With SEC on November 28, 2003)
- RXPEDITE ACORDAMARKETING SERVICES AGREEMENT (Filed With SEC on November 28, 2003)
- WORKPLAN FOR DETAILING SERVICES (Filed With SEC on November 28, 2003)
- LICENSE AGREEMENT BETWEEN ACORDA THERAPEUTICS, INC. AND THE MAYO FOUNDATION FOR EDUCATION AND RESEARCH Dated:September 8, 2000 TABLE OF CONTENTS (Filed With SEC on November 28, 2003)
- COLLABORATION AGREEMENT by and between TEVA PHARMACEUTICAL INDUSTRIES LTD. and ACORDA THERAPEUTICS, INC. (Filed With SEC on November 28, 2003)
- SECURITIES AMENDMENT AGREEMENT AMONG ELAN CORPORATION, PLC, ELAN INTERNATIONAL SERVICES, LTD. and ACORDA THERAPEUTICS, Inc. (Filed With SEC on November 28, 2003)
- FampridineTablets (10mg, 15mg, 20mg, 25mg) Technical Transfer Program Proposal for Commercial Registration For AcordaTherapeutics ProposalNo. ELN-FQ-0001-1002-R4 Dated: February... (Filed With SEC on November 28, 2003)
- AGREEMENT between LONZA BIOLOGICS PLC and ACORDA THERAPEUTICS (Filed With SEC on November 28, 2003)
- LABORATORY SERVICES AGREEMENT (Filed With SEC on November 28, 2003)
- AcordaTherapeutics, Inc. [___] Shares Common Stock UNDERWRITINGAGREEMENT dated [___], 2003 Banc of America Securities LLC Lazard Frres & Co. LLC (Filed With SEC on November 6, 2003)
- SIDE AGREEMENT (Filed With SEC on November 6, 2003)
- AMENDMENT No. 1 TO TERMINATION AND ASSIGNMENT AGREEMENT (Filed With SEC on November 6, 2003)
- AMENDMENT No. 1 TO RUSH PAYMENTS AGREEMENT (Filed With SEC on November 6, 2003)
- ACORDATHERAPEUTICS, INC. 1999EMPLOYEE STOCK OPTION PLAN (Filed With SEC on September 29, 2003)
- PROPOSEDAMENDMENT TO 1999 EMPLOYEE STOCK OPTION PLAN (Filed With SEC on September 29, 2003)
- FIFTHAMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 29, 2003)
- ACORDA Therapeutics (Filed With SEC on September 29, 2003)
- TERMINATIONAND ASSIGNMENT AGREEMENT ELANCORPORATION, PLC ELANINTERNATIONAL SERVICES, LTD. ACORDA THERAPEUTICS, Inc. MSRESEARCH AND DEVELOPMENT CORPORATION INDEX (Filed With SEC on September 29, 2003)
- Date: September 2003 ELAN CORPORATION, PLC. AND ACORDA THERAPEUTICS, INC. AMENDED AND RESTATED LICENSEAGREEMENT INDEX (Filed With SEC on September 29, 2003)
- Date: September2003 ELAN CORPORATION,PLC. AND ACORDA THERAPEUTICS,INC. SUPPLY AGREEMENT (Filed With SEC on September 29, 2003)
- LICENSE AGREEMENT by and between RUSH-PRESBYTERIAN-ST.LUKES MEDICAL CENTER and ACORDA THERAPEUTICS,INC. 1 (Filed With SEC on September 29, 2003)
- RUSH PAYMENTS AGREEMENT (Filed With SEC on September 29, 2003)
- AMENDEDAND RESTATED LICENSE AGREEMENT by and between CANADIANSPINAL RESEARCH ORGANIZATION and ACORDATHERAPEUTICS, INC. (Filed With SEC on September 29, 2003)
- LICENSEAGREEMENT (Filed With SEC on September 29, 2003)
- LICENSE AGREEMENT (Filed With SEC on September 29, 2003)
- LICENSE AGREEMENT (Filed With SEC on September 29, 2003)
- RXPEDITE ACORDA MARKETING SERVICES AGREEMENT (Filed With SEC on September 29, 2003)
- RXPEDITE ACORDAMARKETING SERVICES AGREEMENT (Filed With SEC on September 29, 2003)
- WORKPLAN FOR DETAILING SERVICES (Filed With SEC on September 29, 2003)
- LICENSE AGREEMENT BETWEEN ACORDA THERAPEUTICS, INC. AND THE MAYO FOUNDATION FOR EDUCATION AND RESEARCH Dated:September 8, 2000 TABLE OF CONTENTS (Filed With SEC on September 29, 2003)
- COLLABORATION AGREEMENT by and between TEVA PHARMACEUTICAL INDUSTRIES LTD. and ACORDA THERAPEUTICS, INC. (Filed With SEC on September 29, 2003)
- ACORDATHERAPEUTICS, INC. LIMITEDRECOURSE CONVERTIBLE PROMISSORY NOTE (Filed With SEC on September 29, 2003)
- ACORDATHERAPEUTICS, INC. FULLRECOURSE CONVERTIBLE PROMISSORY NOTE (Filed With SEC on September 29, 2003)
- SECURITIES AMENDMENT AGREEMENT AMONG ELAN CORPORATION, PLC, ELAN INTERNATIONAL SERVICES, LTD. and ACORDA THERAPEUTICS, Inc. (Filed With SEC on September 29, 2003)
- FampridineTablets (10mg, 15mg, 20mg, 25mg) Technical Transfer Program Proposal for Commercial Registration For AcordaTherapeutics ProposalNo. ELN-FQ-0001-1002-R4 Dated: February... (Filed With SEC on September 29, 2003)
- AGREEMENT between LONZA BIOLOGICS PLC and ACORDA THERAPEUTICS (Filed With SEC on September 29, 2003)
- LABORATORY SERVICES AGREEMENT (Filed With SEC on September 29, 2003)